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LABORATORY INVESTIGATION
Elevation of intrarenal adenosine by maleic acid decreases
GFR and renin release
Lois J. AREND, CARL I. THOMPSON, MARILYN A. BRANDT, and WILLIAM S. SPIELMAN
Department of Physiology, Michigan State University, East Lansing, Michigan, USA
Elevation of intrarenat adenosine by maleic acid decreases GFR and
renin release. Maleic acid administration produces a defect in tubular
reabsorption resembling that seen in the Fanconi syndrome and also
causes a decrease in glomerular filtration rate (GFR). The mechanism
by which maleic acid alters renal function is uncertain, though the
tubular defect is known to be associated with decreased ATP levels.
Because of this alteration in nucleotide metabolism the present study
was undertaken to determine the role of elevated endogenous adenosine
in mediating the maleic acid—induced changes in renal function. Since
the renal effects of exogenous adenosine are enhanced by sodium—
depletion and attenuated by sodium—loading, the present study com-
pared the time course of the effects of maleic acid on renal function in
10 dogs maintained on a low sodium diet, and 10 dogs maintained on a
high sodium diet. In additon, we examined the effect of maleic acid on
adenosine levels in renal venous plasma, on the urinary excretion of
adenosine, and the effect of the adenosine antagonist, theophylline, on
the maleic acid—induced changes in renal function. After 100 mm of
maleic acid, GFR was decreased significantly by 55 4% of control in
the sodium—depleted dogs, and by 39 4% of control in the sodium—
loaded dogs. In the sodium—depleted dogs, renin release was also
significantly depressed (12 8% of control) during the infusion of
maleic acid. The fractional excretion of sodium was significantly
increased in both groups. The renal venous concentration of adenosine
and the urinary excretion of adenosine were both significantly increased
during maleic acid. In addition, the infusion of theophylline returned
GFR to 78 8% of control in the sodium-depleted dogs and 97 2%
of control in the sodium—loaded dogs and returned renin release to 61
10% of control, but did not attenuate the maleic acid—induced increase
in fractional sodium excretion. These data suggest that endogenous
adenosine may be involved in the decrease in GFR, but not the decrease
in tubular transport, seen with maleic acid infusion.
Maleic acid administration produces a generalized tubular
transport defect that results in the increased excretion of
sodium, potassium, phosphate, glucose, and amino acids, in
addition to increasing urinary flow rate, and thereby closely
resembles the Fanconi syndrome [1—61. Several studies have
demonstrated that, associated with the defect in reabsorption,
glomerular filtration rate (GFR) is markedly reduced following
maleic acid administration [1—3, 6—101. Relatively little is known
about the mechanism of the fall in GFR.
Previous work has demonstrated that maleic acid lowers
renal cortical adenosine triphosphate (ATP) content [10—121.
Because of the marked alteration of nucleotide metabolism, it
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has been proposed [10] that the fall in GFR is the result of
increased intrarenal levels of adenosine. As a means of testing
this hypothesis, we sought to determine, during the intrarenal
infusion of maleic acid: 1) if the fall in GFR is greater in the
sodium—depleted than in the sodium—loaded dog, thereby mim-
icking the effect of dietary sodium intake on the renal response
to exogenous adenosine infusion [131; 2) if there is a suppres-
sion of renin release, which is also seen with an adenosine
infusion [13, 141; 3) if the fall in GFR is blocked by the
adenosine antagonist, theophylline; and 4) if renal venous and
urinary adenosine concentrations are elevated. Data are pre-
sented indicating that the fall in GFR produced by maleic acid
is mediated by adenosine.
Methods
Experiments were performed on two groups of mongrel dogs
of both sexes, weighing between 10 and 20 kg. One group of 10
dogs (Group I) was maintained on a low—sodium diet (Hill's
Prescription Diet, h/d) of less than 2 mEq sodium/day for seven
to 10 days, and was given 100 mg furosemide, i.v., on the first
day of the dietary regimen. A second group of 10 dogs (Group
II) was fed the same low—sodium food as Group I, which had
been supplemented with 200 mEq NaCl. This diet was main-
tained for 10 to 14 days, and the animals received 15 mg
deoxycorticosterone pivalate (Ciba Pharmaceutical Co.) each
day of the dietary regimen. All dogs were allowed free access to
water. In both groups, each dog received 300 mg lithium
carbonate 24 hours before the experiment.
The dogs were surgically prepared as previously described
[15]. Briefly, the dogs were anesthetized with sodium pentobar-
bital (30 mg/kg, i.v.) and a tracheostomy was performed for
mechanical ventilation with a Harvard respiration pump. Cath-
eters (PR 240) were placed in both femoral arteries for moni-
toring systemic blood pressure and obtaining systemic blood
samples, and in both femoral veins for systemic infusions and
supplemental anesthetic administration. A left flank incision
was made to expose the left renal artery and vein and the ureter.
Small curved needles were placed in the renal artery for
intrarenal infusions and in the renal vein for sampling of the
renal venous effluent. The renal artery needle was kept patent
by a constant infusion of saline at 1.38 ml/min. The ureter was
cannulated with polyethylene tubing. An electromagnetic flow
probe (Zepeda Instrtiments) was placed around the renal artery
for measurement of renal blood flow. Systemic blood pressure
and renal blood flow were recorded on a Hewlett Packard
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Table 1. Time course of effect of maleic acid in sodium—depleted and sodium—loaded dogs
GFR
Period ml/min
RBF
ml/min
MAP
mm Hg
FF RVR FENa
%
Group 1: Sodium—depleted (N = 5)
168 16 127 5 0.35 0.03 0.78 0.06 0.24 0.16Control 32.8 3.4
Maleic acid
60 mm 23.9 4.8" 192 31 116 8" 0.23 004b 0.65 0.07 12.42 2.74"
80 mm 14.9 25b 146 23 114 8b 0.23 0.06" 0.85 0.13 23.90 3.21"
100 mm 14.9 2.6" 152 20 119 6" 0.20 0.07" 0.83 0.15 29.05 3.49"
Group 2: Sodium—loaded (N = 5)
141 15 116 1 0.33 0.05 0.86 0.08 3.08 1.31Control 25.9 4.3
Maleic acid
60 mm 22.0 5.7 121 23 123 2" 0.33 0.08 1.16 0.27 26.33 4.21"
80 mm 18.1 3.7 111 22 121 F' 0.28 0.06 1.28 0.25 32.80 306b
100 mm 15.8 3.4" 134 24 121 F' 0.29 0.10 0.95 0.14 29.77 5.21"
a Values are means SEM. Abbreviations are: GFR, glomerular filtration rate; RBF, renal blood flow; MAP, mean arterial pressure; FF,
filtration fraction; RVR, renal vascular resistance; FE, fractional excretion
b P < 0.05 compared to control
recorder. A 1% solution of inulin (Difco Laboratories, Detroit,
Michigan, USA) was infused at 2 mi/mm into a femoral vein
throughout the experiment to achieve a constant plasma con-
centration of approximately 25 mg/dl. A 60 mm equilibration
period was allowed after completion of the surgical procedure.
Two control clearance periods were performed in each ex-
periment, which consisted of a fifteen minute urine collection
and the collection of systemic arterial and renal venous blood
samples at the mid-point of each period. Saline (0.9%) was used
as the intrarenal infusate for the control periods as well as for
the vehicle in subsequent infusions. The saline was then re-
placed by maleic acid at a dose of 100 mg/kg body wt/hr
(neutralized with NaOH). Ten minute urine collections and
blood samples were obtained at 60 and 80 minutes during the
maleic acid infusion. To complete the time course of the effects
of maleic acid and to serve as a time control for the theophylline
study, urine and blood samples were collected at 100 minutes of
maleic acid in five dogs from each group. In the remaining five
sodium—depleted and five sodium—loaded dogs, an intrarenal
infusion of theophylline (5mol/min) was begun at 90 minutes of
maleic acid. A five minute equilibration period was allowed
after which three five—minute clearance periods were per-
formed. In all experiments, fluid losses, due to the polyuric
effects of maleic acid and theophylline, were replaced by the
intravenous infusion of saline at a rate double to the urine flow
rate, to compensate for tubular dysfunction occurring in the
contralateral kidney, which, from preliminary studies was
found to be similarly affected.
For these studies, adenosine and theophylline were pur-
chased from Sigma Chemical Co. (St. Louis, Missouri, USA)
and maleic acid was purchased from J.T. Baker Chemical Co.
(Phillipsburg, New Jersey, USA).
Inulin concentrations in plasma and urine were determined
by the anthrone method, as described by Davidson and Sackner
[16]. Sodium, potassium, and lithium concentrations were de-
termined by flame photometry. Adenosine levels in plasma and
urine during the control and maleic acid periods were deter-
mined by HPLC as previously described [17]. Plasma renin
activity (PRA) was measured as angiotensin I by radioimmuno-
assay as described by Romero and Strong [18]. Renin release
was calculated as the difference between arterial PRA and renal
venous PRA multiplied by the renal plasma flow. Samples taken
for adenosine and renin measurements were pooled for the two
control periods and for the maleic acid periods. No samples for
measurement of adenosine levels were taken during the
theophylline infusion.
Glomerular filtration rate was calculated as the clearance of
inulin. Changes in the fractional excretion of lithium were used
as an indication of changes in proximal reabsorption.
Statistical significance was determined using two—way anal-
ysis of variance, with Tukey's w-test for multiple comparisons
and paired and unpaired t-tests where appropriate.
Results
The intrarenal infusion of maleic acid resulted in a decrease in
GFR at 60, 80 and 100 minutes in the sodium—depleted and the
sodium—loaded animals (Table 1). GFR was decreased signifi-
cantly by 60 minutes of maleic acid and continued to decrease
for the remainder of the infusion in the sodium—depleted group,
however, in the sodium—loaded group GFR was not signifi-
cantly decreased until 100 minutes. The infusion of theophylline
(Table 2, Figs. 1 and 2) inhibited the further decline in GFR seen
at 100 minutes in the time course study; GFR increased to levels
that were not significantly different from control in both the
sodium—depleted and sodium—loaded animals.
The response of RBF to maleic acid in the sodium—depleted
group is shown in a representative tracing in Figure 1. There
was an immediate increase in RBF at the onset of the infusion
which waned after approximately 60 minutes and fell below the
control level for the remainder of the infusion. With the infusion
of theophylline, RBF returned to the control level. In the
sodium—loaded group, shown in Figure 2, RBF increased only
slightly after the onset of the maleic acid infusion and was not
different than the control level during the remainder of the
infusion. Theophylline infusion in the sodium—loaded group
resulted in a small increase in RBF. Mean arterial pressure
(Table 1) decreased during maleic acid infusion in the sodium—
depleted group, but increased significantly in the sodium—
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Table 2. Effect of theophylline on the maleic acid—induced changes in renal function on sodium—depleted and sodium—loaded dogs
Period
GFR RBF MAP
mI/mm mI/mm mm Hg
Group I: Sodium—depleted (N = 5)
a Values are mean SEM. Abbreviations are the same as in Table I
"p < 0.05 compared to control
40 60 80 95 100 105
Time, mm
Fig. 1. Effect of theophylline on the maleic acid—induced changes in
glomerular filtration rate (GFR) and renal blood flow (RBF) in five
sodium—depleted dogs. Each value represents the mean SEM for the
group. Asterisk indicates F < 0.05, compared to control.
loaded group. Theophylline did not significantly change mean
arterial pressure (Table 2) in either group.
The fractional excretion of sodium was significantly greater in
the sodium—loaded animals than in the sodium—depleted ani-
mals in the control period and was significantly increased to
approximately 30% in both groups, with maleic acid (Table 1).
The infusion of theophylline resulted in a further increase in
fractional sodium excretion. The fractional excretion of lithium
also increased in both groups with maleic acid, The average
plasma lithium concentration in the sodium—depleted group (N
= 10) was 0.56 0.11 mEq/liter. There was a significant
increase in the fractional lithium excretion in this group from a
control value of 22.7 6.4% to 64.9 12.4% (P < 0.05) after
100 minutes of maleate, In many of the sodium—loaded dogs, the
dose of 300 mg lithium carbonate was not sufficient to produce
a measurable plasma lithium concentration. Therefore, for
statistical comparisons, lithium concentrations for all sodium—
loaded dogs (time course and theophylline) were pooled. In six
sodium—loaded dogs, the control plasma lithium concentration
was 0.11 0.01 mEq/liter, and the fractional excretion of
lithium increased from 30.9 7.7% in control to 53.3 10.1%
(P < 0.05) after 60 minutes and to 69.1 10.4% (P < 0.05) after
80 minutes of maleic acid. At 100 minutes of maleic acid, as well
as during the infusion of theophylline, the urine lithium concen-
tration was undetectable in the sodium—loaded group. During
theophylline, in the sodium—depleted group, fractional lithium
FF RVR FENA
%
Control 25.8 4.1 143 15 118 5 0.30 0.04 0.85 0.06 0.76 0.41
Maleic acid
60 mm 16.5 31b 139 24 110 8 0.22 0.04 0.87 0.13 29.84 6.38"
80mm 14.2 1.6" 132 19 109 9 0.20 0.03 0.89 0.14 40.18 7.62"
Maleic acid/theophylline
5 mm 17.7 1.9 140 18 104 8 0.25 0.04 0.79 0.11 56.14 7.97"
10 mm 19.2 2.7 141 18 105 8 0.27 0.06 0.79 0.12 59.12 11.24"
15 mm 19.3 2.8 140 19 100 8h 0.26 0.08 0.79 0.16 64.30 730b
Group 2: Sodium—loaded (N 5)
Control 26.4 3.6 129 12 105 9 0.37 0.06 0.83 0.09 6.13 1.44
Maleic acid
60 mm 24.6 3.5 133 11 121 9" 0.33 0.06 0.92 0.06 34.72 5.19"
80 mm 20.2 1.5" 132 14 117 7' 0.27 0.02 0.93 0.09 45.84 5,4l1
Maleic acid/theophylline
5 mm 25.6 2.3 151 11 116 6" 0.29 0.03 0.78 0.06 48.30 4.77"
10 mm 24.1 2.2 148 11 112 6 0.29 0.04 0.77 0.06 53.04 6.43"
15 mm 24.1 2.2 146 14 109 8 0.29 0.01 0.76 0.07 49.78 5.21"
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Fig. 2. Effect of theophylline on the maleic acid—induced changes in
glomerular filtration rate (GFR) and renal blood flow (RBF) in five
sodium—loaded dogs. Each value represents the mean SEM for the
group. Asterisk indicates P < 0.05, compared to control.
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Control Maleic acid Maleic acid/
theophylline
Fig. 3. Effect of theophylline on the maleic acid—induced decrease in
renin release presented as percent of control. Value during maleic acid
represents the mean SEM for 10 sodium—depleted dogs, value during
maleic acid and theophylline represents the mean SEM for five
sodium—depleted dogs. Asterisk indicates P < 0.05, compared to
control.
excretion increased from 79.1 6.9% at 80 minutes of maleate
to 84.6 9.9% (NS) after 15 minutes of theophylline.
The effect of maleic acid on renin release is shown in Figure
3. The data shown include all 10 of the sodium—depleted animals
during the maleic infusion. During the control period, renin
release averaged 608 253 ng Al/mm. Renin release decreased
significantly (P < 0.05) to 11.9 7.9% of control during maleic
acid and returned to 60.8 9.9% of control (NS) during the
theophylline infusion (N 5).
As shown in Figure 4, the arterial levels of adenosine were
not altered by the infusion of maleic acid in either the
sodium-depleted or the sodium—loaded animals. However, the
renal venous concentration of adenosine increased significantly
during maleic acid, from 0.05 0.01 xM to 0.33 0.06 M in
the sodium-depleted animals and from 0.13 0.02 xM to 0.51
0.10 ILM in the sodium—loaded animals. In addition, the urinary
excretion of adenosine increased significantly, from 0.96 0.23
tmolImin to 7.22 2.26 moI1min in the sodium—depleted
animals and from 1.21 0.17 pmolImin to 18.46 4.81
molImin in the sodium—loaded animals.
Discussion
These studies demonstrate that the effects of maleic acid on
renal function are dependent on the state of sodium balance of
the animal and that the hemodynamic changes can be reversed
by the adenosine receptor antagonist, theophylline. In addition,
these changes in renal function were associated with an in-
crease in the levels of endogenous adenosine.
Several studies have demonstrated that the intravenous or
intrarenal administration of maleic acid results in a profound
decrease in proximal and distal tubular reabsorption [1—61. This
defect in tubular transport is believed to be due to the ability of
maleate to affect mitochondrial metabolic activity [12, 19, 201.
The administration of maleic acid has also been shown to be
associated with a decrease in cortical ATP levels [10—12]. In
addition, a decrease in glomerular filtration rate (GFR) has been
shown to occur during the infusion of maleic acid [1—3, 6—10].
While the mechanism of action of maleic acid to produce
defects in tubular transport has been studied [19—21], the action
of maleic acid to cause a decrease in GFR has not been
extensively examined, though a recent micropuncture study by
Maesaka and McCaffery [9] suggested that the measured de-
cline in GFR is due to a backleak in inulin in a distal portion of
the nephron. The ability of theophylline to reverse the maleic
acid—induced decrease in GFR in the present study, as well as
in a preliminary study by Osswald [10], indicates that in
addition to, or alternative to a backleak of inulin, the decrease
in GFR may be due to an adenosine—mediated mechanism.
The renal actions of exogenous adenosine have been shown
to be dependent on the state of sodium balance of the animal.
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Osswald, et al, have shown that the effects of adenosine on
GFR, renal blood flow (RBF), and renin release are enhanced
by sodium restriction and attenuated by sodium loading [131. In
addition, the renal effects of elevating endogenous adenosine
have also been shown to have a sodium—dependency 117].
Therefore, as a test of the hypothesis that the decrease in GFR
due to maleic acid administration is the result of an increase in
endogenous adenosine, the animals in the present study were
either sodium—depleted or sodium—loaded. The magnitude of
the decrease in GFR was greater in the sodium—depleted than in
the sodium—loaded dogs. In addition to the decrease in GFR,
the change in RBF was more pronounced in the sodium—de-
pleted animals, and there was a decrease in renin release, both
of which are known to occur with the exogenous administration
of adenosine [13, 14] as well as with the elevation of endoge-
nous adenosine levels [17]. These results were true for each
time point during the infusion of maleic acid and support the
hypothesis that intrarenal adenosine mediates these changes.
The possibility exists, however, that the metabolic effects of
maleic acid are altered by the presence of a high sodium diet or
volume expansion and that this alteration in the cellular effect of
maleic acid is responsible for the difference in the functional
responses of the two groups. The fractional excretion of sodium
at 100 minutes was approximately 30% in both the sodi-
um—depleted and the sodium—loaded dogs, and was actually
more pronounced in the sodium—loaded animals at all time
points, indicating that the difference in sodium balance appar-
ently was not the cause of the difference in functional response
between the two groups.
The animals in this study were given lithium carbonate prior
to the experiments with the intention of using fractional lithium
excretion as an index of proximal reabsorption, since it has
been reported that lithium is handled by the kidney at this site
[22]. Previous studies attempting to localize the tubular action
of maleie acid have shown that much of the transport dysfunc-
tion occurs in the proximal tubule [1, 3, 5, 6, 8], with some
reports of dysfunction occurring distally [1, 23]. The increased
fractional excretion of lithium in the present study served as
evidence that the transport defect had occurred. An interesting
finding apart from the increase in fractional lithium excretion
was that, given the same dose in both groups of animals, there
was a consistently lower plasma lithium concentration and
higher control fractional lithium excretion in the sodium—loaded
groups. This may reflect an overall decrease in proximal reab-
sorption due to the volume—expanded state of these animals.
Concomitant with the functional changes resulting from the
infusion of maleic acid, the intrarenal levels of adenosine were
increased as measured by an increase in the level of adenosine
in the renal venous and urinary effluents. In view of work by
other groups [10—12] in which the infusion of maleic acid is
shown to be associated with a decrease in cortical ATP levels,
it was not surprising to find an increase in the levels of
adenosine in the present study. Indeed, it has been reported in
a study by Osswald et al [10] that tissue adenosine concentra-
tion is increased following maleic acid administration in the rat.
However, given the complexity of adenosine metabolism, its
varied cellular sources, and the possibility of intracellular
binding sites, the total tissue level of adenosine is not a reliable
index of extraeellular adenosine, that is, the relevant pool of
adenosine when proposing that adenosine may be involved in
the regulation of renal function. In a recent report from this
laboratory [241, it was shown that, despite similar control
arterial and venous adenosine concentrations, very little of the
venous adenosine was derived from the arterial supply, there-
fore, adenosine measured in the renal vein is primarily of renal
origin. Likewise, a small portion of the adenosine measured in
the urine is from renal production, the majority of adenosine in
the urine being from filtration of the arterial plasma and
incomplete reabsorption in the tubules, Therefore, in the pre-
sent study, adenosine was measured in the renal vein and in the
urine to provide an indication of changes occurring in extracel-
lular adenosine levels, The level of adenosine in the kidney
during maleic acid infusion was increased to approximately the
same magnitude in both groups of dogs and, therefore, the
smaller changes in renal function that occurred in the sodium—
loaded animals were not due to less adenosine being released in
these dogs.
To further test the hypothesis that the increase in intrarenal
adenosine mediates the fall in GFR, RBF, and renin release
seen with maleic acid, the adenosine receptor antagonist,
theophylline, was used. Theophylline, given at a dose that is
known to have no influence on cyclic nueleotide phosphodies-
terase activity [25], reversed the decreases in GFR and RBF in
both the sodium—depleted and the sodium—loaded dogs, and
reversed the decrease in renin release in the sodium—depleted
dogs. The administration of theophylline did not, however,
attenuate the increase in the fractional excretion of sodium,
suggesting that the defect in tubular transport caused by maleie
acid is an adenosine—independent phenomenon while the hemo-
dynamic and renin release effects may be mediated by the
increase in adenosine levels. The inability of theophylline to
completely reverse the fall in GFR could be due to other factors
resulting from the administrarion of maleic acid. As suggested
above, maleic acid may cause a back leak of inulin across the
damaged tubular epithelium. In addition, maleic acid has been
shown previously to produce a bicarbonaturia [2, 6, 7] and may
lead to aeidosis, which can adversely effect GFR. Despite these
possible complications, theophylline largely returns GER to
control, suggesting a major contribution by adenosine to the
decrease in GFR.
The fall in GFR following maleic acid administration may
serve to limit the polyuria associated with this nephrotoxic
insult. It is tempting to speculate that the increased delivery of
fluid and solute from the damaged proximal epithelia following
maleic acid initiates an adenosine—mediated tubuloglomerular
feedback response to reduce the filtered load in an artempt to
limit the excess fluid and solute loss, Previous data have
suggested a role for adenosine in mediation of the feedback
response. Most relevant to the present study are the results of
Schnermann, Osswald and Hermle, which showed that the
feedback response to an increase in tubular flow rate is abol-
ished by theophylline [26]. Coupled with the present results,
this is consistent with adenosine acting as a feedback mediator
in certain circumstances.
The results of this study support the hypothesis that adeno-
sine mediates the renal hemodynamic and renin release effects
of maleie acid. However, while maleic acid is used as an
experimental model of the Panconi syndrome, this study does
not necessarily imply that any changes in renal function that
occur in clinically relevant cases of the Fanconi syndrome are
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mediated by adenosine. What can be inferred from these results
is that endogenous adenosine is capable of altering renal func-
tion in some pathophysiologic or nephrotoxic situations. It
remains to be determined what role adenosine plays in the
normal regulation of renal function.
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